Emory Toolbox

The tools for a faster, smarter nuclear cardiology

How to succeed in today's fast-paced, data-driven, outcomes-based Nuclear Cardiology.

Fast, automatic, 230-rule interpretation with Syntermed IDS Clinical Decision Support

The best, easiest, cloud-based remote reading and reporting by far with Syntermed Live

Improved workflow efficiency with post-facto reorientation

Fast, fewer-clicks, automatically-generated structured natural language reporting with SmartReport

Easier to use.  More workflow-centered than ever.

A better system to evaluate heart failure

Easily capture and demonstrate the value of your procedures for the ASNC ImageGuide Registry

Easy, automatic EMR integration

Absolute Blood Flow and Cardiac Flow Reserve

Request a Free 30 Day Trial

Schedule a Emory

Toolbox 4.0 demo

Watch a 2 min intro to Toolbox 4.0

Now you can get ultimate diagnostic confidence and maximum productivity with Syntermed IDS Clinical Decision Support.  Syntermed IDS is the industry's first and only FDA-approved clinical decision support.  It automatically generates a comprehensive interpretation using over 230 rules to evaluate perfusion, reversibility, function, and patient demographics.  Additional information incorporated into the interpretation (if available) includes prone vs. supine image results, attenuation corrected vs. non-attenuation corrected image results, and quality control data.

Fast, automatic, 230-rule interpretation with Syntermed IDS Clinical Decision Support


Faster, Fewer-Clicks Reporting


SmartReport, powered by Syntermed IDS is a completely integrated ICANL- and ASNC Guildeline-compliant enterprise (client/server) reporting platform that provides automatically-generated natural language and structured reports faster than ever before.

ASNC ImageGuide Registry-Ready

Appropriate Use Criteria continues to gain momentum.  Toolbox 4.0 with SmartReport was built from the ground up to automatically support the ASNC ImageGuide Registry.


Read and report anywhere, anytime, from any system with Syntermed Live, the best, easiest, cloud-based remote reading and reporting by far.

Easy remote reading and reporting

Easier to use.  And more workflow-centered than ever.


Toolbox 4.0 features new, time-saving, workflow-friendly usability and clinical enhancements including, but not limited to, multi-monitor display, dynamic windowing, comprehensive 3D display, improved base detection, diastolic function, % uptake, indexed functional values, viability analysis and Coronary Blood Flow (Q1 2015).

One-way or two-way EMR/HL7 interfaces are available for most EMR providers, via Syntermed Consulting Services Group - with minimal impact on your internal IT resources and at minimal cost.


Easy, automatic EMR integration.

Improved workflow efficiency with post-facto reorientation


Post-Facto reorientation significantly improves workflow effiency by allowing physicians to correct improper SPECT or PET tomogram orientation during image interpretation.

A better system to evaluate heart failure.


Syntermed is the first to support GE's recently approved Adreview (I-123 mlBG) via Adreview Tools.  In conjunction with our industry-leading SyncTool, Emory Toolbox 4.0 provides two marketable ways to deliver advanced clinical solutions to evaluate heart failure.

Introducing FlowTool.  Improved accuracy for detecting patients with balanced reduction of flow.  Now Emory Toolbox allows you to compute absolute blood flow and coronary flow reserve from dynamic PET studies, diagnose balanced flow reductions in triple vessel disease, and diagnose the reduction of hyperemic flow in endothelial disease.

Absolute Blood Flow and Cardiac Flow Reserve


The Tell-Tale Heart:  Ernest Garcia and the

Emory Cardiac Toolbox


This software program, known as the Emory Cardiac Toolbox™ (ECTb™), is one of the most widely applied cardiac imaging systems in the world, and was developed by Ernest V. Garcia, PhD, Professor of Radiology, the Emory University School of Medicine. Garcia, who credits his invention with saving his own life, says the most fundamental question the software addresses is whether a patient has coronary artery disease.